scholarly article | Q13442814 |
P50 | author | Carlos Blanco | Q56089029 |
Mark Olfson | Q91346889 | ||
Steven C Marcus | Q91478905 | ||
P2093 | author name string | Gonzalo Laje | |
Harold Alan Pincus | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 1005-1010 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | American Journal of Psychiatry | Q1935368 |
P1476 | title | Trends in the treatment of bipolar disorder by outpatient psychiatrists | |
P478 | volume | 159 |
Q91318437 | A review of prescribing patterns in 24-hour nurse-staffed community residences in Ireland |
Q30485018 | Abnormalities in brain structure and behavior in GSK-3alpha mutant mice |
Q47294091 | An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms |
Q58720362 | Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea |
Q28478032 | Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature |
Q36634433 | Bipolar depression: diagnostic and treatment considerations |
Q37463232 | Bipolar-I depression outpatient treatment quality and costs in usual care practice |
Q45070754 | Burden of general medical conditions among individuals with bipolar disorder |
Q36013172 | Changes in the quality of care for bipolar I disorder during the 1990s |
Q45751300 | Characteristics of bipolar disorder patients given antidepressants |
Q45227608 | Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder |
Q35190057 | Customization in prescribing for bipolar disorder |
Q22252261 | Cyclothymic disorder: A critical review |
Q38873763 | Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder. |
Q37514635 | Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis |
Q58324361 | Drug prescription in Italian Residential Facilities |
Q82548684 | Effect of antidepressant use on admissions to hospital among elderly bipolar patients |
Q42635317 | Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder. |
Q35334500 | Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders |
Q40041318 | Geographical disparities in prescription practices of lithium and clozapine: a community-based study |
Q61809204 | Identification of factors affecting treatment outcome in bipolar disorder |
Q34905003 | Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement |
Q34272241 | Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India |
Q41285005 | Inhibition of GSK3 by lithium, from single molecules to signaling networks |
Q33529314 | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis |
Q95840818 | Lithium Treatment Over the Lifespan in Bipolar Disorders |
Q38240532 | Lithium for bipolar disorder: a review of the recent literature |
Q28081249 | Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics |
Q34616063 | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial |
Q39238241 | Lithium: A classic drug-Frequently discussed, but, sadly, seldom prescribed! |
Q37402610 | Lithium: a key to the genetics of bipolar disorder |
Q38773608 | Lithiumeter: Version 2.0. |
Q36916509 | Longitudinal course of bipolar I disorder: duration of mood episodes |
Q36902757 | Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions |
Q33652764 | Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics |
Q37671101 | Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission |
Q37460513 | Meta-analysis of the effects of lithium usage on serum creatinine levels |
Q39987572 | Nationwide and population-based prescription patterns in bipolar disorder |
Q45664480 | One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics |
Q33788485 | One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis |
Q39383213 | Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA. |
Q37115466 | Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service |
Q36649087 | Pharmacotherapy of bipolar depression: an update |
Q37740131 | Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies |
Q36228154 | Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies. |
Q37178704 | Predictors of treatment utilization in major depression |
Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
Q36240665 | Primary care and behavioral health practice size: the challenge for health care reform |
Q36682087 | Probability and predictors of treatment-seeking for substance use disorders in the U.S. |
Q93014347 | Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy |
Q44912658 | Quality of care measures for the treatment of bipolar disorder |
Q38605376 | Renal microcysts and lithium |
Q35197367 | Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia. |
Q42771386 | Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression. |
Q53657532 | The Maudsley bipolar disorder project. Clinical characteristics of bipolar disorder I in a Catchment area treatment sample. |
Q41638870 | The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features |
Q36327280 | The burden of general medical conditions in patients with bipolar disorder |
Q47389328 | The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study. |
Q37135244 | The prevalence and correlates of workplace depression in the national comorbidity survey replication |
Q57730484 | Treatment of bipolar depression |
Q35142091 | Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach |
Q35103972 | Treatment of bipolar disorder in the Netherlands and concordance with treatment guidelines: study protocol of an observational, longitudinal study on naturalistic treatment of bipolar disorder in everyday clinical practice |
Q37158292 | Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior |
Q47367652 | Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence? |
Q38219318 | Treatment response and duration of maintenance treatment with adjunctive antidepressants in bipolar depression: A retrospective chart review |
Q37756175 | Trends in antipsychotic prescribing practices in an urban community mental health clinic |
Q34311526 | Unmasking of brugada syndrome by lithium |
Q48568036 | Use of polypharmacy and self-reported mood in outpatients with bipolar disorder |
Q83866936 | Ziprasidone in bipolar disorder |
Q79905027 | [Epidemiology of medication prescriptions in bipolar disorder] |
Q83190702 | [The costs of bipolar disorder] |
Search more.